AMILI is a precision gut microbiome company based in Singapore, serving the region.
Through AMILI's proprietary analytics engine, PRIME, we develop diagnostics tests, predictive algorithms and microbiome-modifying interventions.
Our consumer health arm, BIO & ME, utilises insights from AMILI's database and PRIME to generate Asia-centric solutions towards personalised diet, supplementation and precision health.
AMILI also houses Southeast Asia's first and only gut microbiome bank for clinical use and research.
For more information, visit www.amili.asia.